Add-on combination therapy with monoclonal antibodies: Implications for drug development.
Saved in:
| Title: | Add-on combination therapy with monoclonal antibodies: Implications for drug development. |
|---|---|
| Authors: | Cummings J; Chambers-Grundy Center for Transformative Neuroscience, Department of Brain Health, Kirk Kerkorian School of Medicine, University of Nevada Las Vegas (UNLV), Las Vegas, Nevada, USA. Electronic address: jcummings@cnsinnovations.com., Burstein AH; Alzheimer's Drug Discovery Foundation (ADDF), New York, New York, USA., Fillit H; Alzheimer's Drug Discovery Foundation (ADDF), New York, New York, USA. |
| Source: | The journal of prevention of Alzheimer's disease [J Prev Alzheimers Dis] 2025 Dec; Vol. 12 (10), pp. 100359. Date of Electronic Publication: 2025 Oct 27. |
| Publication Type: | Journal Article; Review |
| Journal Info: | Publisher: Elsevier Country of Publication: United States NLM ID: 101638820 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2426-0266 (Electronic) Linking ISSN: 22745807 NLM ISO Abbreviation: J Prev Alzheimers Dis Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 41145338 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Add-on combination therapy with monoclonal antibodies: Implications for drug development. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Cummings+J%22">Cummings J</searchLink>; Chambers-Grundy Center for Transformative Neuroscience, Department of Brain Health, Kirk Kerkorian School of Medicine, University of Nevada Las Vegas (UNLV), Las Vegas, Nevada, USA. Electronic address: jcummings@cnsinnovations.com.<br /><searchLink fieldCode="AU" term="%22Burstein+AH%22">Burstein AH</searchLink>; Alzheimer's Drug Discovery Foundation (ADDF), New York, New York, USA.<br /><searchLink fieldCode="AU" term="%22Fillit+H%22">Fillit H</searchLink>; Alzheimer's Drug Discovery Foundation (ADDF), New York, New York, USA. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101638820%22">The journal of prevention of Alzheimer's disease</searchLink> [J Prev Alzheimers Dis] 2025 Dec; Vol. 12 (10), pp. 100359. <i>Date of Electronic Publication: </i>2025 Oct 27. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Review – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier%22">Elsevier </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101638820 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2426-0266 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2222745807%22">22745807 </searchLink><i>NLM ISO Abbreviation: </i>J Prev Alzheimers Dis <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41145338 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1016/j.tjpad.2025.100359 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 100359 Titles: – TitleFull: Add-on combination therapy with monoclonal antibodies: Implications for drug development. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Cummings J – PersonEntity: Name: NameFull: Burstein AH – PersonEntity: Name: NameFull: Fillit H IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 12 Text: 2025 Dec Type: published Y: 2025 Identifiers: – Type: issn-electronic Value: 2426-0266 Numbering: – Type: volume Value: 12 – Type: issue Value: 10 Titles: – TitleFull: The journal of prevention of Alzheimer's disease Type: main |
| ResultId | 1 |
